The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

Pulmonary embolism (PE) is a significant cause of morbidity and mortality, particularly in patients classified as acute, ...

‘Training on synthetic fibrosis images achieved a 0.943 ROC-AUC—nearly matching real MRI data (0.952). AI is transforming heart treatment.#aiinhealthcare #medindia ’ Existing methods like ...

Atrial fibrillation is frequently treated with ablation – a procedure where doctors create small, controlled scars to block erratic electrical signals. However, success rates vary considerably ...

James Robson suffers from atrial fibrillation but will compete for Cambridge University at this year's Boat Races Three years ago, James Robson was rowing with a Great Britain team-mate when he ...

We're talking about current issues in atrial fibrillation management. Professor Wellens, I've followed your work with great admiration over the years. Can you tell me how you see the field of ...

In patients with AF, abelacimab, compared with rivaroxaban, is associated with decreased bleeding across multiple bleeding risk categories. Abelacimab is associated with reduced bleeding compared ...

Objective Atrial fibrillation (AF) has emerged as a common condition in older adults. Cardiovascular risk factors only explain about 50% of AF cases. Inflammatory biomarkers may help close this gap as ...

Atrial fibrillation ... between atrial fibrillation and dementia, particularly in younger patients. The researchers suggest that early detection and proactive management of AF in younger ...

Atrial fibrillation (afib ... “These findings highlight the importance of early detection and management of afib,” says Dr. Rodriguez García, “and suggest the need for further research ...

Pulmonary-vein isolation is an effective treatment for paroxysmal atrial fibrillation. Pulsed field ablation (PFA) is a nonthermal ablation method with few adverse effects beyond the myocardium.

There was no association observed between respiratory syncytial virus vaccination and increased risk for atrial fibrillation in older adults with preexisting conditions, supporting the use of RSV ...